Delivery Order SPE2DB22D3004-SPE2DB24FRA36
Award Date
7/11/24
Potential Completion Date
7/12/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "EMERPHED 25 MG/5 ML SYRINGE 5ML" to the Defense Logistics Agency (DLA). The contract has a ceiling value of $4,760.80 and is a Firm Fixed Price Delivery Order with a completion date of May 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
This is a federal contract award valued at $2,952.27 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564287327 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EMERPHED 25 MG/5 ML SYRINGE 5ML. The contract has a Ceiling Value of $3,825.10 and a completion date of April 25, 2023. This award is a Firm Fixed Price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FPX06) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML pharmaceutical products. The $1,312.12 delivery order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), awarded to Amerisourcebergen Drug Corp. for the supply of 4565786556 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The award has a ceiling value of $2,296.21 and a completion date of September 13, 2024. This contract is for the delivery of essential pharmaceutical products to support military treatment facilities and programs. Amerisourcebergen is a major supplier of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,893.93, is for the delivery of EMERPHED 25 MG/5 ML SYRINGE 5ML, a medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,832.78, is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of January 2, 2025. This award is not associated with a set-aside designation. Amerisourcebergen...
This federal contract award is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a for-profit organization and a major pharmaceutical distributor. The contract has a ceiling value of $1,846.10 and is a Firm Fixed Price Delivery Order with a completion date of February 1, 2023. The contract was awarded on January 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,808.57, is a delivery order for the supply of EMERPHED 25 MG/5 ML SYRINGE 5ML, with a completion date of February 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMERPHED 50 MG/10 ML VIAL 10ML, a critical medical product, with a ceiling value of $1,014.24. The delivery order has a firm fixed-price pricing type and an ultimate completion date of July 24, 2024. Amerisourcebergen, through its extensive medical supply chain network, will provide this...